Brian Kirby

14.4k total citations
203 papers, 7.7k citations indexed

About

Brian Kirby is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Brian Kirby has authored 203 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Dermatology, 88 papers in Immunology and 34 papers in Epidemiology. Recurrent topics in Brian Kirby's work include Psoriasis: Treatment and Pathogenesis (79 papers), Dermatology and Skin Diseases (43 papers) and Hidradenitis Suppurativa and Treatments (34 papers). Brian Kirby is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (79 papers), Dermatology and Skin Diseases (43 papers) and Hidradenitis Suppurativa and Treatments (34 papers). Brian Kirby collaborates with scholars based in Ireland, United Kingdom and United States. Brian Kirby's co-authors include Anne‐Marie Tobin, C.E.M. Griffiths, Oliver FitzGerald, Neil Armstrong, Cheryl Sweeney, Rosalind Hughes, Caitriona Ryan, Helen L. Richards, Wolf‐­Henning Boehncke and Dónal G. Fortune and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Brian Kirby

192 papers receiving 7.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Kirby Ireland 48 3.6k 2.8k 1.4k 1.2k 932 203 7.7k
Alexander Egeberg Denmark 50 3.4k 0.9× 4.6k 1.6× 1.6k 1.2× 792 0.7× 621 0.7× 315 8.1k
E.M.G.J. de Jong Netherlands 46 4.3k 1.2× 3.4k 1.2× 1.2k 0.9× 1.1k 0.9× 319 0.3× 315 7.6k
Paolo Gisondi Italy 49 5.8k 1.6× 3.3k 1.2× 2.5k 1.8× 985 0.8× 269 0.3× 285 8.7k
Francesca Sampogna Italy 41 2.1k 0.6× 2.9k 1.0× 532 0.4× 824 0.7× 441 0.5× 156 5.3k
John Koo United States 55 8.0k 2.2× 6.8k 2.4× 1.7k 1.3× 835 0.7× 208 0.2× 339 12.5k
Jacek C. Szepietowski Poland 58 3.7k 1.0× 10.6k 3.7× 2.5k 1.8× 2.5k 2.2× 2.5k 2.7× 637 15.3k
Simon Francis Thomsen Denmark 46 1.3k 0.4× 2.8k 1.0× 931 0.7× 934 0.8× 745 0.8× 351 7.4k
Craig L. Leonardi United States 45 11.4k 3.2× 6.4k 2.2× 2.6k 1.9× 1.2k 1.0× 336 0.4× 133 14.1k
Sonja Ständer Germany 62 1.7k 0.5× 10.3k 3.6× 4.3k 3.1× 1.2k 1.1× 428 0.5× 438 13.9k
Howard Amital Israel 57 2.7k 0.8× 643 0.2× 3.4k 2.5× 1.5k 1.3× 982 1.1× 401 11.5k

Countries citing papers authored by Brian Kirby

Since Specialization
Citations

This map shows the geographic impact of Brian Kirby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Kirby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Kirby more than expected).

Fields of papers citing papers by Brian Kirby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Kirby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Kirby. The network helps show where Brian Kirby may publish in the future.

Co-authorship network of co-authors of Brian Kirby

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Kirby. A scholar is included among the top collaborators of Brian Kirby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Kirby. Brian Kirby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hughes, Rosalind, Collette McCourt, Glen Doherty, et al.. (2025). Inflammatory Bowel Disease Prevalence in Patients with Hidradenitis Suppurativa Using Prospective Symptom-Based Questionnaires and Fecal Calprotectin Testing. Dermatology and Therapy. 15(7). 1901–1913.
2.
4.
5.
Ring, Hans Christian, Jonathan Thorsen, Brian Kirby, et al.. (2024). Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study. British Journal of Dermatology. 190(5). 769–771. 3 indexed citations
6.
Petrasca, Andreea, Róisín Hambly, Conor M. Smith, et al.. (2023). Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa. British Journal of Dermatology. 189(6). 730–740. 27 indexed citations
7.
Kirby, Brian, et al.. (2023). Switching from adalimumab originator to biosimilar: a 3-year retrospective cohort analysis. Clinical and Experimental Dermatology. 48(4). 397–398. 2 indexed citations
8.
Moran, Barry, Conor M. Smith, Alexandra Zaborowski, et al.. (2023). Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin. British Journal of Dermatology. 189(4). 447–458. 18 indexed citations
9.
Hughes, Rosalind, et al.. (2023). Shorter time to initiation of biologic therapy in the setting of a hidradenitis suppurativa specialty clinic. Clinical and Experimental Dermatology. 48(10). 1149–1151. 2 indexed citations
10.
Kirby, Brian, et al.. (2022). Alcohol and Psoriasis for the Dermatologist: Know, Screen, Intervene. American Journal of Clinical Dermatology. 23(6). 881–890. 10 indexed citations
11.
Smith, Conor M., Róisín Hambly, S. Gatault, et al.. (2022). B-cell-derived transforming growth factor-β may drive the activation of inflammatory macrophages and contribute to scarring in hidradenitis suppurativa. British Journal of Dermatology. 188(2). 290–310. 6 indexed citations
12.
Ryan, Caitriona, et al.. (2021). Obstructive sleep apnoea in psoriasis and hidradenitis suppurativa. British Journal of Dermatology. 184(6). 1183–1185. 5 indexed citations
13.
Kirby, Brian, et al.. (2020). Dapsone therapy for hidradenitis suppurativa. British Journal of Dermatology. 183(4). 767–768. 10 indexed citations
14.
Cluxton, Deborah, Andreea Petrasca, Barry Moran, et al.. (2020). Dimethyl fumarate modulates the Treg–Th17 cell axis in patients with psoriasis*. British Journal of Dermatology. 184(3). 495–503. 24 indexed citations
15.
Jennings, L., Róisín Hambly, Rosalind Hughes, Bláithín Moriarty, & Brian Kirby. (2019). Metformin use in hidradenitis suppurativa. Journal of Dermatological Treatment. 31(3). 261–263. 43 indexed citations
16.
Hambly, Róisín & Brian Kirby. (2017). The relevance of serum vitamin D in psoriasis: a review. Archives of Dermatological Research. 309(7). 499–517. 42 indexed citations
17.
Hambly, Róisín, et al.. (2017). Medication adherence among patients with psoriasis on traditional systemic and biologics treatment. British Journal of Dermatology. 178(1). e46–e48. 4 indexed citations
18.
Ryan, Caitriona, Muriel Sadlier, Edward De Vol, et al.. (2015). Genital psoriasis is associated with significant impairment in quality of life and sexual functioning. Journal of the American Academy of Dermatology. 72(6). 978–983. 148 indexed citations
19.
20.
Kelly, G., et al.. (2008). Severe deterioration of psoriasis due to an insulinoma. Clinical and Experimental Dermatology. 33(2). 145–147. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026